라파스

Business Overview

Raphas specializes in the research, development, manufacturing, and sales of patches using dissolvable microneedles technology. Leveraging its proprietary DEN technology, the company produces microneedles at room temperature without heat or UV exposure, enabling applications in sensitive bio-pharmaceuticals. Currently focused on the cosmetics market, Raphas plans to expand into pharmaceuticals, vaccines, and medical devices, with ongoing collaborations with Serum Institute and Boehringer Ingelheim for vaccine and therapeutic patch development.